Moreover, there was a significant reduction in LS-mean change in AUC Glucose0-2h from baseline across the high GLP-1 group [LS-mean change from baseline -263.89 mmol/L (95% CI -384.74, -143.04)]
However, effects are dose-responsive smaller doses usually mean smaller changes
Ozempic Zepbound vs
As more non-weight indications emerge, including potential applications for addiction, Alzheimer disease, fatty liver disease, and chronic kidney disease, the relevance of BMI as the primary gatekeeper will diminish
Molecular mechanisms of insulin resistance
They point to effects beyond appetite suppression, from reduced inflammation to possible direct signalling on tumour cells. F&B takeaway: It almost goes without saying that GLP-1s for cancer prevention or treatment would dramatically accelerate their adoption, both in private use and in public health systems, shifting them firmly into the health space